You can consider Wegovy a revolutionary weight loss drug. It has high efficiency, and hundreds of thousands of overweight and obese people dream of getting it. But so far, the supply of the medicine is limited, which is why it is more challenging to get it than, for example, Saxenda. What company makes Wegovy, and what does it say about its drug?
Wegovy — brand name of the drug containing Semaglutide. Ozempic has the same active ingredient. But, if the latter was developed for the treatment of type 2 diabetes, the former was created specifically to fight excess weight. This effect is due to a higher dosage of the active substance. The maximum single dose of this drug is 2.4 mg, while that of Ozempic is only 1 mg. Who manufactures Wegovy?
Wegovy parent company is Novo Nordisk, also producing Ozempic and Saxenda. It is a Danish company which main goals include the fight against diabetes, obesity and other chronic diseases. It released many innovative products that have received high praise from professionals and patients.
Some facts about the Wegovy maker
The company actively introduces new technologies and develops effective medicines. It focuses its activities on the development of drugs for:
- Type 1 diabetes;
- Type 2 diabetes;
- Obesity;
- Hemophilia;
- Growth disorders.
The company who makes Wegovy medication now produces 50% of all injectable insulin, and more than 34 million people with diabetes use its anti-diabetic products. The company conducts its clinical studies in more than 50 countries. So, the Wegovy manufacturing company deserves respect and trust, and its products are safe and effective.
What does the manufacturer of Wegovy say about its drug? The company notes that the drug fights overweight and obesity in people with BMI ≥ 27 and BMI ≥ 30 and treats diseases caused by excess weight. It recommends combining treatment with increased exercise and a low-calorie diet.
Demand for the drug continues to grow, prompting the company to increase its production capacity. It is expected that there will be no problems with the supply. Now you know who owns Wegovy and what this medicine is for.
FAQ
The Danish company Novo Nordisk is the manufacturer of the drug. The company offers innovative solutions for the treatment of diabetes, obesity and a range of chronic diseases, including hemophilia and growth disorders.
For the treatment of obesity, the company also launched the injectable Saxenda, which active ingredient is Liraglutide. It is available in the dosage of 3 mg.
Both drugs contain the same active ingredient Semaglutide. But the former has a higher dosage of the active substance, which contributes to effective weight loss. Ozempic is primarily for the treatment of diabetes, and its maximum allowable dosage is 1 mg, according to NPS MedicineWise.
Conclusion
The drug manufacturer is the Danish company Novo Nordisk specialising in the production of medicines for the treatment of diabetes and many chronic diseases, including Ozempic and Saxenda.
Today, this medicine is considered the most effective drug for obesity and overweight. The manufacturer recommends strictly following the instructions and combining the drug with exercise and a low-calorie diet to obtain the desired result. In this case, the manufacturer guarantees safety and lasting results from the treatment.
